-
1
-
-
17844373818
-
Changes in beliefs identify unblinding in randomized controlled trials: A method to meet CONSORT guidelines
-
J.R. Rees, T.J. Wade, D.A. Levy, J.M. Colford Jr., and J.F. Hilton Changes in beliefs identify unblinding in randomized controlled trials: a method to meet CONSORT guidelines Contemp Clin Trials 26 2005 25 37
-
(2005)
Contemp Clin Trials
, vol.26
, pp. 25-37
-
-
Rees, J.R.1
Wade, T.J.2
Levy, D.A.3
Colford, Jr.J.M.4
Hilton, J.F.5
-
2
-
-
34547830376
-
Measuring the success of blinding in RCTs: Don't, must, can't or needn't?
-
D.L. Sackett Measuring the success of blinding in RCTs: don't, must, can't or needn't? Int J Epidemiol 36 2007 664 665
-
(2007)
Int J Epidemiol
, vol.36
, pp. 664-665
-
-
Sackett, D.L.1
-
4
-
-
0034686811
-
Blinding in clinical trials and other studies
-
S.J. Day, and D.G. Altman Blinding in clinical trials and other studies BMJ 321 2000 504
-
(2000)
BMJ
, vol.321
, pp. 504
-
-
Day, S.J.1
Altman, D.G.2
-
5
-
-
14144255408
-
Impact of participant and physician intervention preferences on randomized trials: A systematic review
-
M. King, I. Nazareth, F. Lampe, P. Bower, M. Chandler, and M. Morou et al. Impact of participant and physician intervention preferences on randomized trials: a systematic review JAMA 293 2005 1089 1099
-
(2005)
JAMA
, vol.293
, pp. 1089-1099
-
-
King, M.1
Nazareth, I.2
Lampe, F.3
Bower, P.4
Chandler, M.5
Morou, M.6
-
6
-
-
58149269587
-
Patients' preferences within randomised trials: Systematic review and patient level meta-analysis
-
Preference Collaborative Review Group
-
Preference Collaborative Review Group Patients' preferences within randomised trials: systematic review and patient level meta-analysis BMJ 337 2008 a1864
-
(2008)
BMJ
, vol.337
, pp. 1864
-
-
-
7
-
-
84876934772
-
Methodological limitations prevent definitive conclusions on the effects of patients' preferences in randomized clinical trials evaluating musculoskeletal conditions
-
M.R. Franco, M.L. Ferreira, P.H. Ferreira, C.G. Maher, R.Z. Pinto, and D.C. Cherkin Methodological limitations prevent definitive conclusions on the effects of patients' preferences in randomized clinical trials evaluating musculoskeletal conditions J Clin Epidemiol 66 2013 586 598
-
(2013)
J Clin Epidemiol
, vol.66
, pp. 586-598
-
-
Franco, M.R.1
Ferreira, M.L.2
Ferreira, P.H.3
Maher, C.G.4
Pinto, R.Z.5
Cherkin, D.C.6
-
8
-
-
84872778425
-
Insufficient evidence to determine the impact of patient preferences on clinical outcomes in acupuncture trials: A systematic review
-
S.L. Prady, J. Burch, S. Crouch, and H. MacPherson Insufficient evidence to determine the impact of patient preferences on clinical outcomes in acupuncture trials: a systematic review J Clin Epidemiol 66 2013 308 318
-
(2013)
J Clin Epidemiol
, vol.66
, pp. 308-318
-
-
Prady, S.L.1
Burch, J.2
Crouch, S.3
Macpherson, H.4
-
9
-
-
79953853360
-
Determining the impact of informed choice: Separating treatment effects from the effects of choice and selection in randomized trials
-
K.J. McCaffery, R. Turner, P. Macaskill, S.D. Walter, S.F. Chan, and L. Irwig Determining the impact of informed choice: separating treatment effects from the effects of choice and selection in randomized trials Med Decis Making 31 2011 229 236
-
(2011)
Med Decis Making
, vol.31
, pp. 229-236
-
-
McCaffery, K.J.1
Turner, R.2
Macaskill, P.3
Walter, S.D.4
Chan, S.F.5
Irwig, L.6
-
10
-
-
0024602631
-
A two-stage trial design for testing treatment, self-selection and treatment preference effects
-
G. Rücker A two-stage trial design for testing treatment, self-selection and treatment preference effects Stat Med 8 1989 477 485
-
(1989)
Stat Med
, vol.8
, pp. 477-485
-
-
Rücker, G.1
-
11
-
-
73449133360
-
The importance of allocation concealment and patient blinding in osteoarthritis trials: A meta-epidemiologic study
-
E. Nuesch, S. Reichenbach, S. Trelle, A.W. Rutjes, K. Liewald, and R. Sterchi et al. The importance of allocation concealment and patient blinding in osteoarthritis trials: a meta-epidemiologic study Arthritis Rheum 61 2009 1633 1641
-
(2009)
Arthritis Rheum
, vol.61
, pp. 1633-1641
-
-
Nuesch, E.1
Reichenbach, S.2
Trelle, S.3
Rutjes, A.W.4
Liewald, K.5
Sterchi, R.6
-
12
-
-
85047692188
-
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
-
K.F. Schulz, I. Chalmers, R.J. Hayes, and D.G. Altman Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials JAMA 273 1995 408 412
-
(1995)
JAMA
, vol.273
, pp. 408-412
-
-
Schulz, K.F.1
Chalmers, I.2
Hayes, R.J.3
Altman, D.G.4
-
13
-
-
0037098203
-
Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research
-
J.A. Sterne, P. Juni, K.F. Schulz, D.G. Altman, C. Bartlett, and M. Egger Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research Stat Med 21 2002 1513 1524
-
(2002)
Stat Med
, vol.21
, pp. 1513-1524
-
-
Sterne, J.A.1
Juni, P.2
Schulz, K.F.3
Altman, D.G.4
Bartlett, C.5
Egger, M.6
-
14
-
-
40949113623
-
Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: Meta-epidemiological study
-
L. Wood, M. Egger, L.L. Gluud, K.F. Schulz, P. Juni, and D.G. Altman et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study BMJ 336 2008 601 605
-
(2008)
BMJ
, vol.336
, pp. 601-605
-
-
Wood, L.1
Egger, M.2
Gluud, L.L.3
Schulz, K.F.4
Juni, P.5
Altman, D.G.6
|